Cargando…
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related deaths worldwide. With a focus on histology, there are two major subtypes: Non-small cell lung cancer (NSCLC) (the more frequent subtype), and small cell lung cancer (SCLC) (the more aggressive one). Even though SCLC, in general, is a chemosensitive...
Autores principales: | Schulze, Arik Bernard, Evers, Georg, Kerkhoff, Andrea, Mohr, Michael, Schliemann, Christoph, Berdel, Wolfgang E., Schmidt, Lars Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562929/ https://www.ncbi.nlm.nih.gov/pubmed/31108964 http://dx.doi.org/10.3390/cancers11050690 |
Ejemplares similares
-
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017) -
Central airway obstruction treatment with self‐expanding covered Y‐carina nitinol stents: A single center retrospective analysis
por: Schulze, Arik Bernard, et al.
Publicado: (2022) -
Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2020) -
Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision
por: Schmidt, Lars Henning, et al.
Publicado: (2016) -
Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)